All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

glatiramer acetate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
	4880	147245-92-9

Description:

Molecule	Description
Synonyms: glatiramer acetate copaxone protiramer	A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS. Molecular weight: 559.66 Formula: C25H45N5O9 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: 63.32 ALOGS: ROTB: None

Drug dosage:

Dose	Unit	Route
20	mg	P

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

Date	Agency	Company	Orphan
Dec. 20, 1996	FDA	TEVA PHARMS USA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Multiple sclerosis relapse	4140.91	15.37	1433	51123	50872	90525019
Injection site reaction	3112.75	15.37	1360	51196	90720	90485171
Injection site pain	1920.57	15.37	1214	51342	172485	90403406
Injection site erythema	1628.79	15.37	894	51662	97608	90478283
Injection site mass	1522.09	15.37	547	52009	21543	90554348
Immediate post-injection reaction	1169.29	15.37	207	52349	257	90575634
Injection site swelling	1105.13	15.37	585	51971	59254	90516637
Injection site pruritus	990.30	15.37	525	52031	53309	90522582
Multiple sclerosis	815.58	15.37	373	52183	27467	90548424
Injection site urticaria	776.20	15.37	317	52239	17694	90558197
Flushing	684.69	15.37	497	52059	87994	90487897
Injection site bruising	500.85	15.37	335	52221	51972	90523919
Fall	485.25	15.37	941	51615	480869	90095022
Chills	464.70	15.37	472	52084	131509	90444382
Injection site necrosis	380.11	15.37	101	52455	1400	90574491
Off label use	340.09	15.37	109	52447	1102143	89473748
Injection site atrophy	287.90	15.37	72	52484	772	90575119
Injection site induration	283.78	15.37	133	52423	10335	90565556
Urticaria	280.68	15.37	583	51973	312151	90263740
Lipoatrophy	280.26	15.37	59	52497	266	90575625
Product dose omission issue	264.33	15.37	546	52010	291141	90284750
Central nervous system lesion	240.84	15.37	123	52433	11523	90564368
Therapy cessation	240.29	15.37	186	52370	36175	90539716
Influenza like illness	229.89	15.37	258	52298	80353	90495538
Hypoaesthesia	229.00	15.37	539	52017	313671	90262220
Balance disorder	227.55	15.37	281	52275	96799	90479092
Palpitations	216.19	15.37	327	52229	136401	90439490
Chest discomfort	216.07	15.37	329	52227	138036	90437855
Product substitution issue	208.39	15.37	130	52426	17878	90558013
Injection site irritation	202.85	15.37	89	52467	5926	90569965
Injection site warmth	201.57	15.37	126	52430	17389	90558502
Tremor	196.44	15.37	333	52223	152840	90423051
Gait disturbance	187.66	15.37	445	52111	260051	90315840
Magnetic resonance imaging abnormal	183.74	15.37	71	52485	3415	90572476
Injection site haemorrhage	183.06	15.37	143	52413	28175	90547716
Lipodystrophy acquired	181.78	15.37	57	52499	1457	90574434
Infusion related reaction	180.05	15.37	17	52539	416763	90159128
Optic neuritis	179.44	15.37	95	52461	9583	90566308
Throat tightness	177.97	15.37	143	52413	29341	90546550
Rheumatoid arthritis	176.52	15.37	8	52548	362606	90213285
Injection site scar	174.94	15.37	53	52503	1204	90574687
Embolia cutis medicamentosa	171.08	15.37	45	52511	598	90575293
Contraindicated product administered	166.62	15.37	4	52552	320135	90255756
Needle fatigue	166.41	15.37	34	52522	128	90575763
Glossodynia	160.29	15.37	6	52550	321773	90254118
Injection related reaction	160.10	15.37	48	52508	1051	90574840
Joint swelling	157.79	15.37	48	52508	503252	90072639
Abortion	151.15	15.37	58	52498	2737	90573154
Systemic lupus erythematosus	150.50	15.37	17	52539	361879	90214012
Seizure	139.50	15.37	287	52269	152342	90423549
Dyspnoea	137.28	15.37	926	51630	880029	89695862
Urinary tract infection	131.64	15.37	433	52123	305199	90270692
Pericarditis	131.31	15.37	6	52550	270145	90305746
Injection site rash	128.66	15.37	109	52447	24064	90551827
Acute kidney injury	128.41	15.37	17	52539	320370	90255521
Arthropathy	123.99	15.37	30	52526	366212	90209679
Burning sensation	122.56	15.37	167	52389	63285	90512606
Injection site discolouration	122.48	15.37	73	52483	9247	90566644
Toxicity to various agents	120.97	15.37	13	52543	287833	90288058
Injection site indentation	117.42	15.37	29	52527	294	90575597
Lower respiratory tract infection	117.31	15.37	7	52549	250652	90325239
Stomatitis	116.48	15.37	12	52544	274686	90301205
General physical health deterioration	112.79	15.37	33	52523	355082	90220809
Paraesthesia	112.57	15.37	360	52196	249966	90325925
Wound	112.47	15.37	20	52536	302960	90272931
Motor dysfunction	107.07	15.37	89	52467	19141	90556750
Erythema	105.18	15.37	332	52224	228914	90346977
Secondary progressive multiple sclerosis	104.51	15.37	38	52518	1541	90574350
Therapy change	103.71	15.37	63	52493	8259	90567632
Folliculitis	101.08	15.37	4	52552	204349	90371542
Psoriatic arthropathy	99.36	15.37	9	52547	228326	90347565
Loss of consciousness	96.98	15.37	236	52320	140002	90435889
Anaemia	96.34	15.37	42	52514	352760	90223131
Swelling face	95.24	15.37	170	52386	81182	90494709
Product use issue	93.76	15.37	37	52519	329882	90246009
Memory impairment	93.54	15.37	289	52267	196955	90378936
Irritable bowel syndrome	93.51	15.37	7	52549	207441	90368450
Coronavirus infection	93.45	15.37	51	52505	5464	90570427
Abdominal discomfort	92.99	15.37	84	52472	477244	90098647
Chest pain	91.92	15.37	398	52158	319247	90256644
Product use in unapproved indication	91.85	15.37	40	52516	336196	90239695
Depression	90.07	15.37	379	52177	300222	90275669
Breast cancer	86.89	15.37	130	52426	53631	90522260
Diarrhoea	85.20	15.37	271	52285	938919	89636972
Fibromyalgia	84.91	15.37	10	52546	206259	90369632
Feeling cold	83.58	15.37	91	52465	27374	90548517
Feeling hot	81.24	15.37	155	52401	77853	90498038
Injection site nodule	80.36	15.37	43	52513	4430	90571461
Injection site inflammation	79.75	15.37	43	52513	4498	90571393
Blood cholesterol increased	78.78	15.37	13	52543	207999	90367892
Decreased appetite	78.53	15.37	62	52494	376478	90199413
Impaired healing	77.63	15.37	20	52536	234179	90341712
Blister	76.82	15.37	26	52530	254972	90320919
Wheezing	75.79	15.37	22	52534	238058	90337833
Intentional product use issue	74.87	15.37	17	52539	216875	90359016
Osteoarthritis	74.64	15.37	12	52544	195718	90380173
Hepatic enzyme increased	73.23	15.37	61	52495	360675	90215216
Immune reconstitution inflammatory syndrome	72.07	15.37	47	52509	6972	90568919
C-reactive protein increased	71.74	15.37	10	52546	181379	90394512
Type 2 diabetes mellitus	70.01	15.37	16	52540	203228	90372663
Injury	69.06	15.37	15	52541	197334	90378557
Fatigue	68.69	15.37	992	51564	1153031	89422860
Therapeutic product effect decreased	68.25	15.37	38	52518	277533	90298358
Muscle spasms	66.60	15.37	306	52250	251577	90324314
Neutropenia	64.23	15.37	25	52531	224879	90351012
Joint range of motion decreased	62.80	15.37	4	52552	135639	90440252
Expanded disability status scale score increased	62.76	15.37	22	52534	801	90575090
Muscular weakness	61.40	15.37	260	52296	206406	90369485
Progressive multifocal leukoencephalopathy	60.53	15.37	59	52497	15596	90560295
Arthralgia	60.25	15.37	240	52316	778282	89797609
Thrombocytopenia	59.94	15.37	23	52533	208702	90367189
Liver injury	59.60	15.37	13	52543	170554	90405337
Drug interaction	59.56	15.37	44	52512	276409	90299482
Dizziness	59.28	15.37	561	51995	588723	89987168
Ill-defined disorder	58.99	15.37	17	52539	184874	90391017
Hypertension	57.83	15.37	111	52445	457421	90118470
Skin reaction	57.37	15.37	62	52494	18491	90557400
Bladder disorder	56.14	15.37	48	52508	10724	90565167
Pneumonia	55.72	15.37	187	52369	637872	89938019
Oedema	54.39	15.37	24	52532	200271	90375620
JC polyomavirus test positive	52.27	15.37	24	52532	1778	90574113
Sinusitis	51.92	15.37	74	52482	343014	90232877
Completed suicide	50.79	15.37	11	52545	145047	90430844
Peroneal nerve palsy	50.64	15.37	35	52521	5713	90570178
Hyperhidrosis	50.62	15.37	184	52372	136121	90439770
Injection site vesicles	50.30	15.37	31	52525	4169	90571722
Injection site infection	49.28	15.37	25	52531	2307	90573584
Abortion spontaneous	48.56	15.37	101	52455	53955	90521936
Bursitis	48.15	15.37	9	52547	131645	90444246
Injection site haematoma	47.00	15.37	36	52520	6886	90569005
Therapeutic product effect incomplete	46.99	15.37	27	52529	193869	90382022
Blood creatinine increased	46.90	15.37	3	52553	101383	90474508
Confusional state	46.79	15.37	96	52460	386109	90189782
Hypercholesterolaemia	46.63	15.37	3	52553	100889	90475002
Cognitive disorder	46.03	15.37	115	52441	69292	90506599
Lung disorder	45.61	15.37	15	52541	149868	90426023
Therapy interrupted	45.45	15.37	94	52462	50014	90525877
Platelet count decreased	44.79	15.37	12	52544	136957	90438934
Pulmonary fibrosis	44.76	15.37	5	52551	107498	90468393
Pancytopenia	44.46	15.37	8	52548	120255	90455636
Malignant neoplasm progression	44.42	15.37	5	52551	106865	90469026
Peripheral swelling	44.11	15.37	110	52446	412996	90162895
Feeling abnormal	44.04	15.37	203	52353	167032	90408859
Infection	43.87	15.37	90	52466	362004	90213887
Asthma	43.18	15.37	46	52510	242114	90333777
Hemiparesis	43.15	15.37	71	52485	31748	90544143
Muscle spasticity	42.85	15.37	75	52481	35247	90540644
Dry mouth	42.69	15.37	27	52529	184032	90391859
Paralysis	42.04	15.37	42	52514	11436	90564455
Hypotension	41.91	15.37	78	52478	325319	90250572
Heart rate increased	41.57	15.37	152	52404	112750	90463141
Incorrect dose administered by device	41.52	15.37	31	52525	5706	90570185
Obesity	41.28	15.37	6	52550	105501	90470390
Relapsing-remitting multiple sclerosis	41.14	15.37	16	52540	783	90575108
Dyspepsia	40.81	15.37	33	52523	198127	90377764
Delirium	40.68	15.37	6	52550	104353	90471538
Injection site hypoaesthesia	40.30	15.37	15	52541	650	90575241
Anaphylactic reaction	40.29	15.37	127	52429	87397	90488494
Injection site scab	40.06	15.37	15	52541	661	90575230
Autonomic dysreflexia	40.03	15.37	13	52543	373	90575518
Visual impairment	39.65	15.37	167	52389	132198	90443693
Hyponatraemia	39.53	15.37	14	52542	133524	90442367
Vision blurred	39.36	15.37	147	52409	110146	90465745
Trigeminal neuralgia	38.40	15.37	26	52530	4105	90571786
Lymphadenopathy	38.20	15.37	83	52473	45692	90530199
Gastrointestinal disorder	38.19	15.37	56	52500	256631	90319260
Gastrooesophageal reflux disease	37.75	15.37	25	52531	166312	90409579
Circumstance or information capable of leading to device use error	37.67	15.37	11	52545	219	90575672
Intentional overdose	37.50	15.37	5	52551	93829	90482062
Wrong device used	37.48	15.37	8	52548	39	90575852
Movement disorder	37.01	15.37	63	52493	28956	90546935
Discomfort	36.90	15.37	64	52492	274271	90301620
Anaphylactic shock	36.89	15.37	66	52490	31551	90544340
Injection site ulcer	36.72	15.37	14	52542	649	90575242
Muscle tightness	36.55	15.37	42	52514	13397	90562494
Head injury	36.26	15.37	65	52491	31123	90544768
Sleep disorder	35.99	15.37	37	52519	197993	90377898
Demyelination	35.90	15.37	33	52523	8107	90567784
No reaction on previous exposure to drug	35.69	15.37	9	52547	100	90575791
Lip swelling	35.69	15.37	73	52483	38537	90537354
Product storage error	35.67	15.37	51	52505	20190	90555701
Night sweats	35.63	15.37	15	52541	128751	90447140
Therapeutic response decreased	35.34	15.37	5	52551	89724	90486167
Band sensation	35.21	15.37	16	52540	1157	90574734
Speech disorder	35.05	15.37	80	52476	45505	90530386
Insurance issue	34.55	15.37	37	52519	10921	90564970
Injection site injury	34.39	15.37	15	52541	984	90574907
Injection site discomfort	34.12	15.37	28	52528	5912	90569979
Pharyngeal oedema	34.07	15.37	41	52515	13730	90562161
Inflammation	34.03	15.37	32	52524	178560	90397331
Drug abuse	33.85	15.37	4	52552	82343	90493548
Psoriasis	33.81	15.37	22	52534	147732	90428159
Lymphopenia	33.68	15.37	53	52503	22828	90553063
Wound infection	33.53	15.37	10	52546	106392	90469499
Urinary incontinence	32.36	15.37	69	52487	37497	90538394
Injection site anaesthesia	32.17	15.37	7	52549	38	90575853
Weight increased	32.13	15.37	129	52427	417798	90158093
Electrocardiogram QT prolonged	31.11	15.37	3	52553	72453	90503438
Pleural effusion	31.06	15.37	13	52543	111978	90463913
Cough	30.88	15.37	110	52446	368852	90207039
Skin indentation	30.77	15.37	7	52549	48	90575843
Anxiety	30.60	15.37	294	52262	309478	90266413
Malignant melanoma	30.39	15.37	37	52519	12539	90563352
Haemoglobin decreased	29.72	15.37	30	52526	161926	90413965
Relapsing multiple sclerosis	29.24	15.37	9	52547	216	90575675
Nephrolithiasis	29.12	15.37	78	52478	49007	90526884
Maternal exposure during breast feeding	28.97	15.37	26	52530	6194	90569697
Sensory disturbance	28.89	15.37	40	52516	15373	90560518
Grip strength decreased	28.63	15.37	9	52547	92567	90483324
Nasopharyngitis	28.63	15.37	130	52426	406974	90168917
Limb discomfort	28.39	15.37	66	52490	37994	90537897
Upper respiratory tract infection	28.16	15.37	20	52536	128298	90447593
Alopecia	28.14	15.37	170	52386	494901	90080990
Neutrophil count decreased	28.14	15.37	4	52552	71528	90504363
Wrong technique in product usage process	27.73	15.37	98	52458	71473	90504418
Progressive multiple sclerosis	27.72	15.37	14	52542	1280	90574611
Weight decreased	27.50	15.37	120	52436	379790	90196101
Vertigo	27.40	15.37	96	52460	69715	90506176
Hyperkalaemia	27.09	15.37	3	52553	64961	90510930
Haemorrhagic adrenal infarction	26.92	15.37	6	52550	37	90575854
Hypokalaemia	26.78	15.37	22	52534	131094	90444797
Constipation	26.64	15.37	79	52477	280316	90295575
Medication error	26.59	15.37	8	52548	84644	90491247
Device mechanical issue	26.57	15.37	13	52543	1110	90574781
Septic shock	26.35	15.37	8	52548	84152	90491739
Sciatica	26.19	15.37	13	52543	101369	90474522
Hot flush	26.17	15.37	85	52471	59403	90516488
Back pain	26.08	15.37	290	52266	316885	90259006
Ankle fracture	25.68	15.37	44	52512	20326	90555565
Injury associated with device	25.55	15.37	21	52535	4443	90571448
Condition aggravated	25.40	15.37	222	52334	595323	89980568
Maternal exposure during pregnancy	25.11	15.37	319	52237	359744	90216147
Renal impairment	25.08	15.37	15	52541	105406	90470485
Productive cough	24.73	15.37	7	52549	77056	90498835
Hypersensitivity	24.55	15.37	385	52171	454292	90121599
Wrong technique in device usage process	24.47	15.37	23	52533	5812	90570079
Bradycardia	24.46	15.37	9	52547	83838	90492053
Interstitial lung disease	24.40	15.37	7	52549	76398	90499493
Arthritis	24.39	15.37	37	52519	167278	90408613
Foot deformity	24.27	15.37	3	52553	59648	90516243
Gastrointestinal haemorrhage	24.19	15.37	11	52545	90237	90485654
Cardiac failure	24.12	15.37	17	52539	109479	90466412
Abdominal pain	23.48	15.37	134	52422	395587	90180304
Panic attack	23.37	15.37	49	52507	26316	90549575
Skin mass	23.27	15.37	25	52531	7405	90568486
Kinematic imbalances due to suboccipital strain	23.04	15.37	4	52552	4	90575887
Taste disorder	22.95	15.37	4	52552	61542	90514349
Needle issue	22.94	15.37	34	52522	13900	90561991
Abdominal pain upper	22.92	15.37	107	52449	332567	90243324
Oedema peripheral	22.85	15.37	75	52481	257840	90318051
Respiratory failure	22.81	15.37	21	52535	118397	90457494
Hypoaesthesia oral	22.77	15.37	36	52520	15564	90560327
Monoplegia	22.55	15.37	18	52538	3656	90572235
Injection site paraesthesia	22.45	15.37	10	52546	690	90575201
Rectal haemorrhage	22.32	15.37	10	52546	82734	90493157
Nail disorder	21.67	15.37	4	52552	59063	90516828
Injection site coldness	21.60	15.37	6	52550	99	90575792
White blood cell count decreased	21.54	15.37	40	52516	167069	90408822
Manufacturing product shipping issue	21.33	15.37	6	52550	104	90575787
Osteoporosis	21.24	15.37	15	52541	96516	90479375
Autoimmune disorder	21.13	15.37	9	52547	76735	90499156
Overdose	21.00	15.37	37	52519	157672	90418219
Loss of personal independence in daily activities	20.92	15.37	29	52527	136076	90439815
Exostosis	20.83	15.37	3	52553	53131	90522760
Hypoxia	20.73	15.37	8	52548	72391	90503500
Dyspnoea exertional	20.68	15.37	8	52548	72280	90503611
Wrong schedule	20.68	15.37	8	52548	386	90575505
Exposure during pregnancy	20.66	15.37	70	52486	238340	90337551
Liver disorder	20.54	15.37	24	52532	121245	90454646
Fluid retention	20.31	15.37	13	52543	88078	90487813
Necrosis	20.28	15.37	22	52534	6588	90569303
Neoplasm malignant	20.26	15.37	54	52502	33826	90542065
Normal newborn	20.22	15.37	43	52513	23319	90552572
Injection site cellulitis	20.21	15.37	12	52544	1509	90574382
Hepatic cirrhosis	19.83	15.37	6	52550	63247	90512644
Diplopia	19.48	15.37	48	52508	28666	90547225
Depressed level of consciousness	19.31	15.37	9	52547	72775	90503116
Myelitis	19.13	15.37	13	52543	2065	90573826
Scar	19.08	15.37	33	52523	15362	90560529
Atrial fibrillation	19.04	15.37	30	52526	133581	90442310
Anaplastic large cell lymphoma T- and null-cell types	18.90	15.37	5	52551	68	90575823
Herpes simplex reactivation	18.88	15.37	10	52546	1009	90574882
Injection site fibrosis	18.83	15.37	4	52552	19	90575872
Device malfunction	18.61	15.37	39	52517	20938	90554953
Frequent bowel movements	18.59	15.37	5	52551	56930	90518961
Uterine leiomyosarcoma	18.50	15.37	4	52552	21	90575870
Asthenia	18.45	15.37	422	52134	533329	90042562
Near death experience	18.10	15.37	9	52547	796	90575095
Drug ineffective for unapproved indication	18.06	15.37	8	52548	66636	90509255
Nasal sinus cancer	18.04	15.37	4	52552	24	90575867
Skin irritation	17.97	15.37	30	52526	13573	90562318
Swelling	17.94	15.37	156	52400	418902	90156989
Nonspecific reaction	17.75	15.37	14	52542	2795	90573096
Rhabdomyolysis	17.71	15.37	4	52552	51252	90524639
Oxygen saturation decreased	17.44	15.37	22	52534	107461	90468430
Spinal cord operation	17.28	15.37	3	52553	3	90575888
Musculoskeletal pain	17.18	15.37	47	52509	171204	90404687
Caesarean section	17.02	15.37	35	52521	18542	90557349
Eye swelling	16.73	15.37	46	52510	29340	90546551
Neuralgia	16.65	15.37	48	52508	31452	90544439
Blindness	16.55	15.37	43	52513	26525	90549366
Hypoglycaemia	16.53	15.37	10	52546	69838	90506053
Micturition urgency	16.51	15.37	26	52530	11207	90564684
Post procedural complication	16.42	15.37	35	52521	19007	90556884
Injection site extravasation	16.30	15.37	23	52533	8996	90566895
Injection site oedema	16.16	15.37	11	52545	1752	90574139
Pregnancy	16.08	15.37	75	52481	61972	90513919
Thyroid cancer	16.02	15.37	19	52537	6265	90569626
Haematochezia	15.63	15.37	11	52545	70902	90504989
Ataxia	15.37	15.37	33	52523	18009	90557882
Anal incontinence	15.37	15.37	31	52525	16199	90559692

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Multiple sclerosis relapse	1303.94	24.65	364	11061	13900	42596010
Injection site reaction	915.23	24.65	283	11142	15438	42594472
Injection site pain	525.79	24.65	272	11153	57526	42552384
Injection site erythema	485.82	24.65	188	11237	20007	42589903
Immediate post-injection reaction	334.23	24.65	50	11375	36	42609874
Multiple sclerosis	268.61	24.65	94	11331	7504	42602406
Injection site swelling	255.06	24.65	113	11312	16860	42593050
Injection site mass	220.87	24.65	84	11341	8491	42601419
Injection site necrosis	214.13	24.65	46	11379	558	42609352
Injection site pruritus	199.37	24.65	80	11345	9325	42600585
Fall	148.49	24.65	242	11183	234278	42375632
Flushing	141.29	24.65	100	11325	36928	42572982
Injection site urticaria	135.61	24.65	46	11379	3337	42606573
Hypoaesthesia	125.36	24.65	123	11302	71340	42538570
Injection site bruising	109.47	24.65	56	11369	11469	42598441
Gait disturbance	107.86	24.65	132	11293	97868	42512042
Balance disorder	106.69	24.65	94	11331	47551	42562359
Embolia cutis medicamentosa	103.40	24.65	23	11402	331	42609579
Urticaria	98.58	24.65	110	11315	73926	42535984
Central nervous system lesion	85.81	24.65	42	11383	7828	42602082
Off label use	84.64	24.65	33	11392	638302	41971608
Magnetic resonance imaging abnormal	70.83	24.65	24	11401	1734	42608176
Expanded disability status scale score increased	67.10	24.65	17	11408	437	42609473
Secondary progressive multiple sclerosis	63.51	24.65	16	11409	402	42609508
Progressive multiple sclerosis	60.37	24.65	14	11411	245	42609665
Product substitution issue	58.71	24.65	37	11388	11253	42598657
Product dose omission issue	58.26	24.65	128	11297	154237	42455673
Chills	57.78	24.65	96	11329	93970	42515940
Motor dysfunction	56.14	24.65	32	11393	8114	42601796
Acute kidney injury	55.55	24.65	15	11410	367322	42242588
Urinary tract infection	55.28	24.65	97	11328	99187	42510723
Injection site discolouration	53.67	24.65	20	11405	1906	42608004
Injection site irritation	52.75	24.65	19	11406	1645	42608265
Fatigue	51.81	24.65	242	11183	435399	42174511
Chest discomfort	51.81	24.65	74	11351	63542	42546368
Injection site induration	51.63	24.65	23	11402	3464	42606446
Tremor	50.50	24.65	92	11333	96837	42513073
Injection site scar	47.88	24.65	13	11412	440	42609470
Muscular weakness	47.01	24.65	82	11343	83416	42526494
Toxicity to various agents	46.64	24.65	4	11421	229132	42380778
Injection site rash	46.38	24.65	25	11400	5687	42604223
Injection site vesicles	45.35	24.65	16	11409	1304	42608606
Influenza like illness	45.24	24.65	49	11376	31791	42578119
Muscle spasms	45.23	24.65	82	11343	85962	42523948
Depression	45.01	24.65	95	11330	111268	42498642
Injection site atrophy	44.63	24.65	9	11416	78	42609832
Anaemia	41.29	24.65	12	11413	280266	42329644
Hypersensitivity	39.34	24.65	70	11355	72300	42537610
Therapy cessation	39.18	24.65	37	11388	20413	42589497
Gait inability	37.55	24.65	38	11387	22795	42587115
Injection site inflammation	36.23	24.65	13	11412	1113	42608797
Paraesthesia	36.07	24.65	68	11357	73391	42536519
Toxic neuropathy	35.74	24.65	11	11414	584	42609326
Injection site warmth	34.37	24.65	16	11409	2667	42607243
Therapy change	33.46	24.65	18	11407	4077	42605833
Memory impairment	33.16	24.65	53	11372	50169	42559741
Burning sensation	32.79	24.65	34	11391	20979	42588931
Palpitations	32.71	24.65	53	11372	50744	42559166
Neutropenia	32.32	24.65	7	11418	199424	42410486
Injection site haemorrhage	32.08	24.65	26	11399	11710	42598200
Visual impairment	30.55	24.65	47	11378	43066	42566844
Drug interaction	30.27	24.65	17	11408	266982	42342928
Dyspnoea	30.08	24.65	212	11213	442409	42167501
Injection site scab	30.07	24.65	6	11419	49	42609861
Muscle spasticity	29.69	24.65	20	11405	6802	42603108
Injection site haematoma	29.47	24.65	13	11412	1912	42607998
Coronavirus infection	29.41	24.65	18	11407	5196	42604714
Swelling face	28.44	24.65	36	11389	27518	42582392
Hypotension	28.35	24.65	17	11408	257614	42352296
Thrombocytopenia	28.27	24.65	8	11417	190271	42419639
Pleurothotonus	28.08	24.65	11	11414	1200	42608710
Optic neuritis	27.81	24.65	16	11409	4126	42605784
Product use in unapproved indication	26.95	24.65	8	11417	184448	42425462
Wrong device used	26.13	24.65	5	11420	32	42609878
Demyelination	24.68	24.65	14	11411	3515	42606395

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Multiple sclerosis relapse	3474.62	17.27	1124	41501	49116	110497558
Injection site reaction	2636.39	17.27	1064	41561	88006	110458668
Injection site pain	1908.77	17.27	1055	41570	176867	110369807
Injection site erythema	1652.40	17.27	779	41846	93397	110453277
Injection site mass	1202.45	17.27	425	42200	24188	110522486
Injection site swelling	1033.36	17.27	495	42130	61295	110485379
Injection site pruritus	981.67	17.27	451	42174	50807	110495867
Immediate post-injection reaction	803.53	17.27	140	42485	291	110546383
Injection site urticaria	749.23	17.27	273	42352	16942	110529732
Flushing	605.79	17.27	420	42205	104316	110442358
Multiple sclerosis	554.79	17.27	246	42379	25452	110521222
Injection site bruising	525.86	17.27	296	42329	50967	110495707
Fall	398.70	17.27	779	41846	602703	109943971
Chills	357.74	17.27	403	42222	190177	110356497
Hypoaesthesia	298.10	17.27	476	42149	313747	110232927
Injection site necrosis	292.58	17.27	78	42547	1688	110544986
Product dose omission issue	284.28	17.27	472	42153	321310	110225364
Off label use	275.20	17.27	118	42507	1500067	109046607
Urticaria	240.15	17.27	436	42189	318421	110228253
Therapy cessation	229.29	17.27	167	42458	44690	110501984
Central nervous system lesion	219.10	17.27	111	42514	15442	110531232
Injection site atrophy	217.17	17.27	48	42577	451	110546223
Balance disorder	210.89	17.27	242	42383	116318	110430356
Influenza like illness	206.32	17.27	210	42415	88202	110458472
Product substitution issue	203.97	17.27	121	42504	22940	110523734
Injection site induration	201.62	17.27	95	42530	11288	110535386
Embolia cutis medicamentosa	200.47	17.27	51	42574	912	110545762
Tremor	182.85	17.27	300	42325	201932	110344742
Palpitations	181.59	17.27	263	42362	158949	110387725
Magnetic resonance imaging abnormal	180.66	17.27	65	42560	3880	110542794
Gait disturbance	174.34	17.27	352	42273	277856	110268818
Chest discomfort	173.77	17.27	270	42355	173578	110373096
Injection site warmth	168.92	17.27	97	42528	17308	110529366
Acute kidney injury	168.09	17.27	23	42602	635407	109911267
Injection site haemorrhage	162.09	17.27	120	42505	32908	110513766
Optic neuritis	155.38	17.27	79	42546	11068	110535606
Injection site scar	154.55	17.27	43	42582	1097	110545577
Injection site irritation	152.62	17.27	61	42564	4863	110541811
Throat tightness	138.71	17.27	110	42515	33379	110513295
Toxicity to various agents	138.04	17.27	13	42612	480542	110066132
Lipodystrophy acquired	133.16	17.27	54	42571	4470	110542204
Lipoatrophy	129.14	17.27	33	42592	601	110546073
Secondary progressive multiple sclerosis	119.96	17.27	38	42587	1531	110545143
Injection related reaction	119.75	17.27	38	42587	1540	110545134
Burning sensation	118.93	17.27	140	42485	69072	110477602
Anaemia	118.91	17.27	32	42593	547054	109999620
Dyspnoea	118.14	17.27	779	41846	1106093	109440581
Injection site rash	116.96	17.27	86	42539	23333	110523341
Therapy change	116.93	17.27	63	42562	9934	110536740
Urinary tract infection	108.85	17.27	324	42301	325958	110220716
Paraesthesia	107.26	17.27	290	42335	276231	110270443
Injection site discolouration	105.45	17.27	57	42568	9046	110537628
Motor dysfunction	105.02	17.27	82	42543	24324	110522350
Chest pain	103.82	17.27	350	42275	376025	110170649
Erythema	103.52	17.27	296	42329	291151	110255523
Expanded disability status scale score increased	99.14	17.27	29	42596	889	110545785
Product use in unapproved indication	97.50	17.27	26	42599	447351	110099323
Rheumatoid arthritis	94.93	17.27	5	42620	299608	110247066
Memory impairment	94.56	17.27	224	42401	196720	110349954
Progressive multifocal leukoencephalopathy	90.76	17.27	76	42549	24880	110521794
Fatigue	90.27	17.27	786	41839	1215172	109331502
Infusion related reaction	87.22	17.27	20	42605	381142	110165532
Depression	81.27	17.27	288	42337	317047	110229627
Stomatitis	81.15	17.27	6	42619	270236	110276438
Injection site nodule	79.90	17.27	38	42587	4608	110542066
General physical health deterioration	79.85	17.27	32	42593	425263	110121411
Swelling face	79.38	17.27	134	42491	92187	110454487
Injection site indentation	78.44	17.27	19	42606	275	110546399
Decreased appetite	76.83	17.27	44	42581	475802	110070872
Muscle spasms	76.04	17.27	258	42367	277899	110268775
Loss of consciousness	74.19	17.27	204	42421	196102	110350572
Lower respiratory tract infection	74.14	17.27	5	42620	243101	110303573
Feeling hot	74.07	17.27	129	42496	90977	110455697
Drug interaction	72.88	17.27	52	42573	500131	110046543
Pericarditis	71.52	17.27	3	42622	219111	110327563
Joint swelling	71.41	17.27	41	42584	442804	110103870
Thrombocytopenia	71.00	17.27	23	42602	348862	110197812
Injection site inflammation	69.97	17.27	35	42590	4736	110541938
Immune reconstitution inflammatory syndrome	68.69	17.27	54	42571	16172	110530502
Completed suicide	68.37	17.27	7	42618	242374	110304300
Injection site vesicles	66.16	17.27	33	42592	4438	110542236
Needle fatigue	66.15	17.27	23	42602	1241	110545433
Neutropenia	65.85	17.27	31	42594	374589	110172085
Pneumonia	65.70	17.27	151	42474	876563	109670111
Dizziness	65.66	17.27	477	42148	697716	109848958
Feeling cold	65.55	17.27	73	42552	33914	110512760
Hypotension	63.46	17.27	65	42560	523784	110022890
Systemic lupus erythematosus	63.06	17.27	11	42614	254327	110292347
Diarrhoea	62.91	17.27	227	42398	1139278	109407396
Pancytopenia	61.95	17.27	5	42620	209608	110337066
Hyponatraemia	59.58	17.27	7	42618	217646	110329028
Drug abuse	56.05	17.27	3	42622	177408	110369266
Visual impairment	55.11	17.27	144	42481	134284	110412390
Seizure	55.10	17.27	199	42426	220986	110325688
Abortion spontaneous	55.02	17.27	67	42558	34215	110512459
Psoriatic arthropathy	54.68	17.27	6	42619	196755	110349919
Fibromyalgia	53.65	17.27	3	42622	170906	110375768
Arthropathy	53.34	17.27	22	42603	287500	110259174
Platelet count decreased	52.87	17.27	12	42613	230431	110316243
Intentional product use issue	52.85	17.27	15	42610	247891	110298783
Therapeutic product effect incomplete	52.67	17.27	11	42614	223794	110322880
Malignant neoplasm progression	52.04	17.27	4	42621	174563	110372111
Feeling abnormal	51.46	17.27	170	42455	180541	110366133
Blood creatinine increased	49.76	17.27	6	42619	182883	110363791
Folliculitis	49.53	17.27	4	42621	167649	110379025
C-reactive protein increased	48.71	17.27	12	42613	217907	110328767
Insurance issue	46.40	17.27	36	42589	10576	110536098
Hyperhidrosis	45.36	17.27	167	42458	187131	110359543
Muscular weakness	44.66	17.27	202	42423	248266	110298408
Wheezing	43.49	17.27	22	42603	255208	110291466
Muscle spasticity	43.34	17.27	61	42564	35854	110510820
Irritable bowel syndrome	43.20	17.27	6	42619	164209	110382465
Muscle injury	42.62	17.27	3	42622	140804	110405870
Product storage error	42.46	17.27	47	42578	21681	110524993
Product use issue	42.06	17.27	35	42590	311660	110235014
Autonomic dysreflexia	41.97	17.27	13	42612	486	110546188
Breast cancer	41.47	17.27	62	42563	38480	110508194
Cognitive disorder	41.38	17.27	99	42526	87412	110459262
Gastrointestinal haemorrhage	41.37	17.27	7	42618	165511	110381163
Renal impairment	40.92	17.27	11	42614	188434	110358240
Incorrect dose administered by device	40.90	17.27	28	42597	6786	110539888
Lip swelling	40.21	17.27	71	42554	50596	110496078
Skin reaction	40.06	17.27	45	42580	21099	110525575
Vision blurred	40.01	17.27	125	42500	128897	110417777
Hepatic enzyme increased	39.76	17.27	39	42586	320853	110225821
Blood cholesterol increased	39.72	17.27	11	42614	184774	110361900
Osteoarthritis	39.01	17.27	11	42614	182612	110364062
Injection site scab	38.67	17.27	13	42612	633	110546041
Death	38.61	17.27	139	42486	698730	109847944
Injection site discomfort	38.22	17.27	27	42598	6880	110539794
Blister	38.14	17.27	20	42605	227356	110319318
Injection site haematoma	37.83	17.27	24	42601	5122	110541552
Respiratory failure	37.53	17.27	18	42607	215314	110331360
Therapeutic product effect decreased	37.42	17.27	24	42601	244292	110302382
Intentional overdose	36.91	17.27	4	42621	132497	110414177
Interstitial lung disease	36.86	17.27	5	42620	139329	110407345
JC polyomavirus test positive	36.74	17.27	18	42607	2329	110544345
Septic shock	36.54	17.27	8	42617	157520	110389154
Peroneal nerve palsy	36.50	17.27	27	42598	7387	110539287
Lung disorder	36.38	17.27	12	42613	180035	110366639
Overdose	35.76	17.27	23	42602	233771	110312903
Hypertension	35.64	17.27	91	42534	509993	110036681
Neutrophil count decreased	35.41	17.27	3	42622	120938	110425736
Hot flush	34.84	17.27	78	42547	65958	110480716
Wound	34.59	17.27	24	42601	234413	110312261
Bladder disorder	34.59	17.27	31	42594	11106	110535568
Coronavirus infection	34.56	17.27	29	42596	9516	110537158
Pruritus	34.45	17.27	359	42266	581201	109965473
Liver injury	34.16	17.27	8	42617	150405	110396269
Confusional state	34.00	17.27	82	42543	468598	110078076
Haemoglobin decreased	33.46	17.27	28	42597	248699	110297975
Hypoxia	33.44	17.27	5	42620	129510	110417164
Anxiety	33.04	17.27	237	42388	344841	110201833
Hypersensitivity	32.83	17.27	267	42358	403731	110142943
Demyelination	32.81	17.27	28	42597	9401	110537273
Obesity	32.67	17.27	3	42622	113348	110433326
Cardiac failure	32.22	17.27	16	42609	187610	110359064
Injection site infection	32.18	17.27	17	42608	2576	110544098
Impaired healing	31.98	17.27	18	42607	196699	110349975
Injection site ulcer	31.13	17.27	12	42613	868	110545806
No reaction on previous exposure to drug	31.11	17.27	9	42616	265	110546409
Electrocardiogram QT prolonged	31.10	17.27	3	42622	108957	110437717
Delirium	31.02	17.27	7	42618	135018	110411656
Paralysis	30.93	17.27	34	42591	15566	110531108
Joint range of motion decreased	30.78	17.27	5	42620	121827	110424847
Muscle tightness	30.71	17.27	33	42592	14729	110531945
Type 2 diabetes mellitus	30.60	17.27	15	42610	177217	110369457
Speech disorder	30.57	17.27	71	42554	61498	110485176
Asthma	30.33	17.27	31	42594	250260	110296414
Oedema	30.32	17.27	22	42603	209954	110336720
Oedema peripheral	30.27	17.27	50	42575	328610	110218064
Injection site cellulitis	30.16	17.27	15	42610	2005	110544669
Gastrooesophageal reflux disease	29.93	17.27	16	42609	179960	110366714
Renal failure	29.87	17.27	26	42599	226548	110320126
Relapsing-remitting multiple sclerosis	29.73	17.27	15	42610	2067	110544607
Heart rate increased	29.72	17.27	122	42503	143712	110402962
Pharyngeal oedema	29.49	17.27	34	42591	16394	110530280
White blood cell count decreased	29.43	17.27	27	42598	229363	110317311
Abdominal discomfort	29.28	17.27	68	42557	393790	110152884
Pleural effusion	29.26	17.27	16	42609	177693	110368981
Injury	29.13	17.27	16	42609	177249	110369425
Trigeminal neuralgia	28.80	17.27	19	42606	4333	110542341
Bradycardia	28.67	17.27	12	42613	155505	110391169
Vertigo	28.64	17.27	86	42539	86784	110459890
Injection site injury	28.50	17.27	12	42613	1092	110545582
Back pain	28.43	17.27	242	42383	370754	110175920
Sepsis	28.14	17.27	52	42573	327294	110219380
Rectal haemorrhage	27.96	17.27	6	42619	119827	110426847
Movement disorder	27.58	17.27	50	42575	36354	110510320
Pain in extremity	27.56	17.27	298	42327	486820	110059854
Injection site coldness	27.37	17.27	7	42618	128	110546546
Condition aggravated	26.60	17.27	170	42455	734666	109812008
Injection site hypoaesthesia	26.52	17.27	10	42615	681	110545993
Progressive multiple sclerosis	26.40	17.27	12	42613	1312	110545362
Dry mouth	26.29	17.27	23	42602	199925	110346749
Sensory disturbance	26.25	17.27	33	42592	17396	110529278
Diplopia	26.16	17.27	53	42572	41841	110504833
Atrial fibrillation	26.09	17.27	30	42595	229612	110317062
Ill-defined disorder	26.00	17.27	14	42611	156839	110389835
Bursitis	25.65	17.27	9	42616	129909	110416765
Hemiparesis	25.60	17.27	54	42571	43849	110502825
Wrong technique in product usage process	25.59	17.27	83	42542	87265	110459409
Malignant melanoma	25.47	17.27	32	42593	16859	110529815
Hypokalaemia	25.21	17.27	20	42605	182428	110364246
Arthralgia	24.95	17.27	187	42438	779445	109767229
Intentional product misuse	24.91	17.27	10	42615	132894	110413780
Limb discomfort	24.70	17.27	51	42574	40803	110505871
Hypercholesterolaemia	24.65	17.27	3	42622	90834	110455840
Injection site abscess	24.46	17.27	13	42612	1993	110544681
Maternal exposure during breast feeding	24.46	17.27	17	42608	4221	110542453
Rhabdomyolysis	24.36	17.27	8	42617	120393	110426281
Cardiac arrest	24.26	17.27	24	42601	196729	110349945
Gastrointestinal disorder	24.00	17.27	35	42590	241917	110304757
Myelitis	23.65	17.27	15	42610	3198	110543476
Sleep disorder	23.61	17.27	25	42600	198619	110348055
Primary progressive multiple sclerosis	23.44	17.27	6	42619	110	110546564
Urinary incontinence	23.00	17.27	55	42570	48532	110498142
Anaphylactic shock	22.96	17.27	57	42568	51489	110495185
Lymphopenia	22.95	17.27	49	42576	40121	110506553
Cardio-respiratory arrest	22.91	17.27	8	42617	115828	110430846
Abdominal pain	22.73	17.27	111	42514	512878	110033796
Headache	22.67	17.27	471	42154	881906	109664768
Constipation	22.60	17.27	67	42558	357719	110188955
Injection site oedema	22.57	17.27	12	42613	1842	110544832
Productive cough	22.42	17.27	8	42617	114297	110432377
Drug ineffective for unapproved indication	22.32	17.27	6	42619	102832	110443842
Panic attack	22.25	17.27	40	42585	28900	110517774
Inflammation	22.22	17.27	25	42600	193213	110353461
Hypoaesthesia oral	22.20	17.27	30	42595	16972	110529702
Injection site paraesthesia	22.03	17.27	9	42616	759	110545915
Head injury	21.78	17.27	50	42575	42967	110503707
Invasive ductal breast carcinoma	21.64	17.27	19	42606	6627	110540047
Medication error	21.32	17.27	7	42618	105359	110441315
Encephalopathy	21.22	17.27	3	42622	81052	110465622
Peripheral swelling	21.20	17.27	82	42543	403952	110142722
Haematochezia	21.15	17.27	9	42616	115515	110431159
Paraparesis	21.08	17.27	16	42609	4550	110542124
Wrong technique in device usage process	21.02	17.27	19	42606	6882	110539792
Dyspnoea exertional	20.90	17.27	7	42618	104053	110442621
Scar	20.85	17.27	29	42596	16852	110529822
Thyroid cancer	20.70	17.27	18	42607	6196	110540478
Cough	20.38	17.27	100	42525	461541	110085133
Temperature intolerance	20.36	17.27	26	42599	13924	110532750
Upper respiratory tract infection	19.96	17.27	13	42612	131315	110415359
Ataxia	19.89	17.27	39	42586	30069	110516605
Sinusitis	19.88	17.27	54	42571	296634	110250040
Urticarial vasculitis	19.86	17.27	9	42616	977	110545697
Anaphylactic reaction	19.83	17.27	92	42533	114208	110432466
Night sweats	19.39	17.27	14	42611	133969	110412705
Herpes simplex reactivation	19.29	17.27	10	42615	1458	110545216
Acute respiratory failure	19.21	17.27	3	42622	75257	110471417
Liver disorder	19.14	17.27	16	42609	142227	110404447
Anal incontinence	19.02	17.27	32	42593	21932	110524742
Manufacturing product shipping issue	18.80	17.27	5	42620	107	110546567
Skin mass	18.78	17.27	21	42604	9795	110536879
Weight decreased	18.64	17.27	105	42520	467952	110078722
Dyspepsia	18.57	17.27	28	42597	190937	110355737
Epistaxis	18.37	17.27	14	42611	130358	110416316
White matter lesion	18.17	17.27	12	42613	2742	110543932
Ophthalmic herpes zoster	18.16	17.27	13	42612	3382	110543292
Frequent bowel movements	17.88	17.27	3	42622	71387	110475287
Somnolence	17.85	17.27	57	42568	297392	110249282
Drug administered in wrong device	17.59	17.27	5	42620	138	110546536
Chronic kidney disease	17.43	17.27	4	42621	76287	110470387
Ascites	17.36	17.27	7	42618	92801	110453873
Maternal exposure during pregnancy	17.32	17.27	162	42463	254721	110291953
Oxygen saturation decreased	17.30	17.27	21	42604	156961	110389713

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	L03AX13	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSTIMULANTS IMMUNOSTIMULANTS Other immunostimulants
MeSH PA	D000276	Adjuvants, Immunologic
MeSH PA	D007155	Immunologic Factors
MeSH PA	D007166	Immunosuppressive Agents
MeSH PA	D018501	Antirheumatic Agents
CHEBI has role	CHEBI:35610	antineoplastic agent
CHEBI has role	CHEBI:35705	immunosuppressive agent
CHEBI has role	CHEBI:39456	antiglaucoma drug
CHEBI has role	CHEBI:66981	ophthalmology drug

Related Drugs by ATC class:

L03AX Other immunostimulants 15 drugs

cridanimodelapegademasehistamineleniolisiblentinanmavorixaformifamurtidemotixafortidepegademasepidotimodplerixaforroquinimex show all 15 →

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Multiple sclerosis	indication	24700007	DOID:2377

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
5M691HL4BO	UNII
D04318	KEGG_DRUG
4020989	VUID
N0000179467	NUI
4020989	VANDF
C0289884	UMLSCUI
CHEBI:749565	CHEBI
CHEMBL1201507	ChEMBL_ID
D000068717	MESH_DESCRIPTOR_UI
135779	RXNORM
10204	MMSL
262778	MMSL
4781	MMSL
006395	NDDF
108755008	SNOMEDCT_US

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	0378-6960	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	27 sections
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	0378-6961	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	27 sections
Glatopa	HUMAN PRESCRIPTION DRUG LABEL	1	0781-3234	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	26 sections
Glatopa	HUMAN PRESCRIPTION DRUG LABEL	1	0781-3250	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	26 sections
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	0832-6084	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	25 sections
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	0832-6085	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	25 sections
GLATIRAMER ACETATE	HUMAN PRESCRIPTION DRUG LABEL	1	11797-764	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	1 sections
GLATIRAMER ACETATE	HUMAN PRESCRIPTION DRUG LABEL	1	11797-765	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	1 sections
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	47335-990	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	26 sections
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	47335-991	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	26 sections
Glatopa	HUMAN PRESCRIPTION DRUG LABEL	1	63629-8815	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	26 sections
Glatopa	HUMAN PRESCRIPTION DRUG LABEL	1	63629-8816	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	26 sections
Copaxone	HUMAN PRESCRIPTION DRUG LABEL	1	68546-317	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	NDA	25 sections
Copaxone	HUMAN PRESCRIPTION DRUG LABEL	1	68546-325	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	NDA	25 sections
GLATIRAMER ACETATE	HUMAN PRESCRIPTION DRUG LABEL	1	70710-1548	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	24 sections
GLATIRAMER ACETATE	HUMAN PRESCRIPTION DRUG LABEL	1	70710-1549	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	24 sections
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	82983-429	INJECTION, SOLUTION	20 mg	SUBCUTANEOUS	ANDA	27 sections
Glatiramer Acetate	HUMAN PRESCRIPTION DRUG LABEL	1	82983-430	INJECTION, SOLUTION	40 mg	SUBCUTANEOUS	ANDA	27 sections